Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611001021965Phase 2Completed
Phase 2 trial of hypertonic saline and Normal Saline-Benha University in sepsis (2 arms), sponsored by Royal Perth Hospital. Primary endpoint: Circulating interleukin-1 level change from baseline. Started Nov 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611001021965.